Items where authors include "Marks, D.I."
Article
Creasey, T., Barretta, E., Ryan, S.L. et al. (15 more authors) (2022) Genetic and genomic analysis of acute lymphoblastic leukaemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials. Haematologica, 107 (9). pp. 2051-2063. ISSN 0390-6078
Marks, D.I., Clifton-Hadley, L., Copland, M. et al. (12 more authors) (2022) In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial. The Lancet Haematology, 9 (4). e276-e288. ISSN 2352-3026
Galleu, A., Milojkovic, D., Deplano, S. et al. (21 more authors) (2019) Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival. British Journal of Haematology, 185 (1). pp. 89-92. ISSN 0007-1048
Morley, N.J. and Marks, D.I. (2016) Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia. Expert Review of Anticancer Therapy, 16 (2). pp. 159-164. ISSN 1473-7140